In vivo and in vitro effects of homocysteine on Na+,K +-ATPase activity in parietal, prefrontal and cingulate cortex of young rats

International Journal of Developmental Neuroscience

Volumn 22, Issue 4, 2004, Pages 185-190

  Matté, Cristiane ^a   Monteiro, Siomara C ^a   Calcagnotto, Thiago ^a   Bavaresco, Caren S ^a   Netto, Carlos Alexandre ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Homocysteine; Na+,K+ ATPase; Parietal and cingulate cortex; Prefrontal

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); HOMOCYSTEINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; HOMOCYSTINURIA; HYPERHOMOCYSTEINEMIA; NONHUMAN; OXIDATIVE STRESS; PARIETAL LOBE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUERPERIUM; RAT; SYNAPTIC MEMBRANE;

AMIDINES; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GYRUS CINGULI; HOMOCYSTEINE; HOMOCYSTINURIA; NA(+)-K(+)-EXCHANGING ATPASE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; SYNAPTIC MEMBRANES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 3042740660     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2004.05.007     Document Type: Article

References (38)

1. +-pump activity: pathways between receptors and effectors. NIPS. 10:1995;253-259
2. Bostom A.G., Rosemberg I.H., Silbershatz H., Jacques P.F., Selhub J., D'Agostino R.B., Wilson P.W., Wolf P.A. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann. Intern. Med. 131:1999;352-355
3. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274:1995;1049-1057
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-die-binding. Anal. Biochem. 72:1976;248-254
5. 2+-stimulated ATPase activity. Anal. Biochem. 157:1986;375-380
6. Eikelboom J.W., Lonn E., Genest J., Hankey G., Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 131:1999;363-375
7. Erecinska M., Silver I.A. Ions and energy in mammalian brain. Prog. Neurobiol. 16:1994;37-71
8. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldeyde and 4-hydroxynonenal. Methods Enzymol. 186:1990;407-421
9. + pump in epilepsy. Ann. Neurol. 16(Suppl.):1984;128-134
10. +-ATPase activities in Alzheimer's disease brains. Neurosci. Lett. 254:1998;141-144
11. Hogg N. The effect of cyst(e)ine on the auto-oxidation of homocysteine. Free Radic. Biol. Med. 27:1999;28-33
12. Jones D.H., Matus A.I. Isolation of plasma synaptic membrane from brain by combination flotation-sedimentation density gradient centrifugation. Biochim. Biophys. Acta. 356:1974;276-287
13. Kubová H., Folbergrová J., Mares P. Seizures induced by homocysteine in rats during ontogenesis. Epilepsia. 36:1995;750-756
14. Kuhn W., Roebroek R., Blom H., van Oppenraaij D., Przuntek H., Kretschmer A., Buttner T., Woitalla D., Muller T. Elevated plasma levels of homocysteine in Parkinson's disease. Eur. Neurol. 40:1998;225-227
15. Leblhuber F., Walli J., Artner-Dworzak E., Vrecko K., Widner B., Reibnegger G., Fuchs D. Hyperhomocysteinemia in dementia. J. Neural Transm. 107:2000;343-353
16. Lees G.J. Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience. 54:1993;287-322
17. Lissi E., Pascual C., Del Castillo M.D. Luminol luminescence induced by 2, 2′-azo-bis (2-amidinopropane) thermolysis. Free Radic. Res. Commun. 17:1992;299-311
18. Lowry O.H., Rosebrough A.L., Farr A.L., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275
19. Manoach D.S. Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr. Res. 60:2003;285-298
20. Maratos E.J., Dolan R.J., Morris J.S., Henson R.N.A., Rugg M.D. Neural activity associated with episodic memory for emotional context. Neuropsychologia. 39:2001;910-920
21. Mottaghy F.M., Gangitano M., Krause B.J., Pascual-Leone A. Chronometry of parietal and prefrontal activations in verbal working memory revealed by transcranial magnetic stimulation. NeuroImage. 18:2003;565-575
22. Mudd, S.H., Levy, H.L., Skovby, F., 2001. Disorders of transsulfuration. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.), The Metabolic and Molecular Bases of Inherited Disease, vol. 2. McGraw-Hill, New York, pp. 1279-1327.
23. Reis E.A., Zugno A.I., Franzon R., Tagliari B., Matté C., Lamers M.L., Netto C.A., Wyse A.T.S. Pretreatment with Vitamins E and C prevent the impairment of memory caused by homocysteine administration in rats. Metab. Brain Dis. 17:2002;211-217
24. Rushworth M.F., Hadland K.A., Gaffan D., Passingham R.E. The effect of cingulate cortex lesions on task switching and working memory. J. Cogn. Neurosci. 15:2003;338-353
25. Seshadri S., Beiser A., Selhulb J., Jacques P.F., Rosemberg I.H., D'Agostino R.B., Wilson P.W.F., Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346:2002;476-483
26. +-ATPase activity from rat cerebral cortex by guanidino compounds accumulating in hyperarginemia. Brain Res. 838:1999;78-84
27. +-ATPase activity induced by homocysteine is probably mediated by oxidative stress. Neurochem. Res. 26:2001;1195-1200
28. +-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem. Res. 27:2002a;1585-1590
29. +-ATPase activity by the metabolites accumulating in homocystinuria. Metab. Brain Dis. 17:2002b;83-91
30. Streck E.L., Vieira P.S., Wannmacher C.M.D., Dutra-Filho C.S., Wajner M., Wyse A.T.S. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab. Brain Dis. 18:2003;147-154
31. Temple M.E., Luzier A.B., Kaazierad D.J. Homocysteine as a risk factor for atherosclerosis. Ann. Pharmacother. 34:2000;57-65
32. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem. J. 22:1984;301-307
33. +-ATPase. Biochim. Biophys. Acta. 987:1989;75-82
34. Welch G.N., Upchurch G.R., Loscalzo J. Homocysteine, oxidative stress, and vascular disease. Hosp. Pract. 32:1997;81-92
35. +-ATPase activity in the synaptic plasma membrane from the cerebral cortex of rats subjected to chemically induced phenylketonuria. Med. Sci. Res. 23:1995;261-262
36. +-ATPase activity after brain ischemia. Neurochem. Res. 25:2000;969-973
37. +-ATPase activity in midbrain of rats subjected to arginine administration. Neurochem. Res. 26:2001;515-520
38. +-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by Vitamins E and C treatment. Neurochem. Res. 27:2002;1677-1681